These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20471373)

  • 21. Identification of a quorum-sensing signal molecule in the facultative intracellular pathogen Brucella melitensis.
    Taminiau B; Daykin M; Swift S; Boschiroli ML; Tibor A; Lestrate P; De Bolle X; O'Callaghan D; Williams P; Letesson JJ
    Infect Immun; 2002 Jun; 70(6):3004-11. PubMed ID: 12010991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The sheathed flagellum of Brucella melitensis is involved in persistence in a murine model of infection.
    Fretin D; Fauconnier A; Köhler S; Halling S; Léonard S; Nijskens C; Ferooz J; Lestrate P; Delrue RM; Danese I; Vandenhaute J; Tibor A; DeBolle X; Letesson JJ
    Cell Microbiol; 2005 May; 7(5):687-98. PubMed ID: 15839898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subversion of innate immune responses by Brucella through the targeted degradation of the TLR signaling adapter, MAL.
    Sengupta D; Koblansky A; Gaines J; Brown T; West AP; Zhang D; Nishikawa T; Park SG; Roop RM; Ghosh S
    J Immunol; 2010 Jan; 184(2):956-64. PubMed ID: 20018612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and characterization of a novel bacterial virulence factor that shares homology with mammalian Toll/interleukin-1 receptor family proteins.
    Newman RM; Salunkhe P; Godzik A; Reed JC
    Infect Immun; 2006 Jan; 74(1):594-601. PubMed ID: 16369016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The stringent response mediator Rsh is required for Brucella melitensis and Brucella suis virulence, and for expression of the type IV secretion system virB.
    Dozot M; Boigegrain RA; Delrue RM; Hallez R; Ouahrani-Bettache S; Danese I; Letesson JJ; De Bolle X; Köhler S
    Cell Microbiol; 2006 Nov; 8(11):1791-802. PubMed ID: 16803581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors.
    DiPerna G; Stack J; Bowie AG; Boyd A; Kotwal G; Zhang Z; Arvikar S; Latz E; Fitzgerald KA; Marshall WL
    J Biol Chem; 2004 Aug; 279(35):36570-8. PubMed ID: 15215253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic analysis of Brucella melitensis and Brucella ovis for identification of virulence factor using bioinformatics approachs.
    Paci V; Krasteva I; Orsini M; Di Febo T; Luciani M; Perletta F; Di Pasquale A; Mattioli M; Tittarelli M
    Mol Cell Probes; 2020 Oct; 53():101581. PubMed ID: 32428653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic island 2 of Brucella melitensis is a major virulence determinant: functional analyses of genomic islands.
    Rajashekara G; Covert J; Petersen E; Eskra L; Splitter G
    J Bacteriol; 2008 Sep; 190(18):6243-52. PubMed ID: 18641138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cold shock protein A plays an important role in the stress adaptation and virulence of Brucella melitensis.
    Wang Z; Wang S; Wu Q
    FEMS Microbiol Lett; 2014 May; 354(1):27-36. PubMed ID: 24661136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy evaluation of live Escherichia coli expression Brucella P39 protein combined with CpG oligodeoxynucleotides vaccine against Brucella melitensis 16M, in BALB/c mice.
    Al-Mariri A; Mahmoud NH; Hammoud R
    Biologicals; 2012 Mar; 40(2):140-5. PubMed ID: 22296786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Vaccine Candidates against Brucella melitensis Identified through Reverse Vaccinology Approach.
    Vishnu US; Sankarasubramanian J; Gunasekaran P; Rajendhran J
    OMICS; 2015 Nov; 19(11):722-9. PubMed ID: 26479901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coincidence cloning recovery of Brucella melitensis RNA from goat tissues: advancing the in vivo analysis of pathogen gene expression in brucellosis.
    Boggiatto PM; Fitzsimmons D; Bayles DO; Alt D; Vrentas CE; Olsen SC
    BMC Mol Biol; 2018 Aug; 19(1):10. PubMed ID: 30068312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Twin-Arginine Translocation System Is Important for Stress Resistance and Virulence of Brucella melitensis.
    Yan X; Hu S; Yang Y; Xu D; Li H; Liu W; He X; Li G; Cai W; Bu Z
    Infect Immun; 2020 Oct; 88(11):. PubMed ID: 32778612
    [No Abstract]   [Full Text] [Related]  

  • 34. Comprehensive Identification of Immunodominant Proteins of Brucella abortus and Brucella melitensis Using Antibodies in the Sera from Naturally Infected Hosts.
    Wareth G; Eravci M; Weise C; Roesler U; Melzer F; Sprague LD; Neubauer H; Murugaiyan J
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27144565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA-seq reveals the critical role of CspA in regulating Brucella melitensis metabolism and virulence.
    Wang Z; Liu W; Wu T; Bie P; Wu Q
    Sci China Life Sci; 2016 Apr; 59(4):417-24. PubMed ID: 26740105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular investigation of virulence factors of Brucella melitensis and Brucella abortus strains isolated from clinical and non-clinical samples.
    Mirnejad R; Jazi FM; Mostafaei S; Sedighi M
    Microb Pathog; 2017 Aug; 109():8-14. PubMed ID: 28506887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacterial TIR-containing proteins and host innate immune system evasion.
    Rana RR; Zhang M; Spear AM; Atkins HS; Byrne B
    Med Microbiol Immunol; 2013 Feb; 202(1):1-10. PubMed ID: 22772799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification, refolding and characterization of the trimeric Omp2a outer membrane porin from Brucella melitensis.
    Roussel G; Matagne A; De Bolle X; Perpète EA; Michaux C
    Protein Expr Purif; 2012 Jun; 83(2):198-204. PubMed ID: 22538317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis.
    Al-Mariri A; Abbady AQ
    J Infect Dev Ctries; 2013 Apr; 7(4):329-37. PubMed ID: 23592643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model.
    Tadepalli G; Singh AK; Balakrishna K; Murali HS; Batra HV
    Mol Immunol; 2016 Mar; 71():34-41. PubMed ID: 26826463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.